Search

everythinglearnresearchcommunity

for

Search:↓

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

Hormones and genes affect hair growth and male baldness.

Liquorice may reduce testosterone and affect male reproductive organs, potentially helping treat conditions like prostate cancer.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Antiandrogen therapy helps treat genetic hair loss.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Androgens can both increase body hair and cause scalp hair loss.

Dosing time affects finasteride's effectiveness and safety in rats.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Skin problems in PCOS, like excess hair, acne, and hair loss, may not always indicate high male hormone levels and need careful diagnosis for proper treatment.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

Benign ovarian tumors can cause excess male hormones and related conditions in postmenopausal women.

CEC levels may be a useful marker for predicting prostate cancer progression.

The meeting covered advances in understanding hair growth, causes of hair loss, and potential treatments.

Androgenetic alopecia is a long-term, immune-related disorder that starts during puberty due to androgen secretion, and it might be improved with iron tablets, platelet transfusion, and anti-inflammation therapy.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.